Physicochemical Properties
Molecular Formula | C18H34CLN2O8PS |
Molecular Weight | 504.95 |
Exact Mass | 504.146 |
Elemental Analysis | C, 42.81; H, 6.79; Cl, 7.02; N, 5.55; O, 25.35; P, 6.13; S, 6.35 |
CAS # | 24729-96-2 |
Related CAS # | Clindamycin hydrochloride;21462-39-5;Clindamycin palmitate hydrochloride;25507-04-4;Clindamycin;18323-44-9;Clindamycin phosphate hydrochloride;64023-51-4 |
PubChem CID | 443385 |
Appearance | White to off-white solid powder. |
Density | 1.4±0.1 g/cm3 |
Boiling Point | 159°C |
Melting Point | 114ºC |
Index of Refraction | 1.577 |
LogP | 0.93 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Heavy Atom Count | 31 |
Complexity | 658 |
Defined Atom Stereocenter Count | 9 |
SMILES | Cl[C@@]([H])(C([H])([H])[H])[C@]([H])([C@]1([H])[C@@]([H])([C@@]([H])([C@]([H])([C@]([H])(O1)SC([H])([H])[H])OP(=O)(O[H])O[H])O[H])O[H])N([H])C([C@]1([H])C([H])([H])[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])N1C([H])([H])[H])=O |
InChi Key | UFUVLHLTWXBHGZ-MGZQPHGTSA-N |
InChi Code | InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14-,15+,16+,18+/m0/s1 |
Chemical Name | (2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate |
Synonyms | Cleocin T; Clinda-Derm; Clindagel; Evoclin; U 28508; U-28508; U28508 |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | Antibiotic, Bacterial |
References |
[1]. Eur J Clin Pharmacol. 2017 Feb;73(2):251-253. [2]. J Dermatol. 2018 Aug;45(8):951-962. [3]. Gynecol. 2020, 47(4), 516–518. [4]. Ann Clin Microbiol Antimicrob. 2018 Oct 20;17(1):38. |
Additional Infomation |
Clindamycin Phosphate is the phosphate salt form of clindamycin, a semi-synthetic, chlorinated broad spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin phosphate is used in topical preparations. See also: Clindamycin (has active moiety); Benzoyl Peroxide; Clindamycin Phosphate (component of); Clindamycin phosphate; tretinoin (component of) ... View More ... |
Solubility Data
Solubility (In Vitro) | H2O : 100 mg/mL (198.04 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (99.02 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.9804 mL | 9.9020 mL | 19.8039 mL | |
5 mM | 0.3961 mL | 1.9804 mL | 3.9608 mL | |
10 mM | 0.1980 mL | 0.9902 mL | 1.9804 mL |